Eli Lilly is 'reaping the whirlwind' for aggressive marketing of Zyprexa that has caused suffering and deaths.
Zyprexa is being avoided by doctors they aren't prescribing it for new patients at all anymore.
--
Daniel Haszard Zyprexa patient who got diabetes from it.

This is fantastic news. You've done an outstanding piece of journalism with your Zyprexa Chronicles Philip! That alone deserves an award. Great work.

This is great news. When a judge actually shows some tendency to value the lives of people labeled as having severe mental illness, it's a big deal.

I also give you an award Philip. Your work has contributed to this.
You must be sure you make a difference!

I think it is sickening that the judge would not permit class-action law suits for individual victims but is more than happy to do so for large insurance companies, labor unions, and the like. Just the other day, I spent about an hour emailing with a distraught Mom who had a (at long last) showdown with an army of Lilly-ites, their own dispicable lawyers, and a fortunately nice moderator. Even though their son was killed, and their suit went in early in the process, their attorneys goofed up and their settlement was chump change. This is a couple (no more children left) who were originally told they would receive a substantial amount - which they could have used.

I don't know if there is a way to get more money to the victims, or a way to bring a fraud case that will put these evil men in jail, but I plan to try to find out.

I think Judge Weinstein is a far from admireable man.

I am relatively new to this site. What I have read in your pages just confirms for me that my diabetes is a result of taking Zyprexa years ago. I always knew that the psych meds had messed with me in so many ways, and I always suspected the diabetes was just more fallout from that. I am grateful to your work for letting me know that I wasn't being "paranoid" in my suspicion, and it is a relief to know that I am not alone in being a survivor/victim of psych meds.

I just made a small donation to your site, and hope I will be able to contribute more money in the future. This is important work you do. Thank you from the bottom of my heart.

Philip,

been following your Zyprexa reporting on this site for - a couple years, forever/

I agree, you should get an award for your tireless reporting and researching.

Everything I have learned about what is good in journalism and what a good journalist is, I have learned from you.

hi my son system is just messed up because of zyprexa and now seroquel.i hope and pray that the victims can get more money from zyprexa because what they have given them is really nothing and there is no amount of money that can give my son and others their health back only the Lord can heal them of these terrible things their body goes through.the companies can get millions and billions but the victims can only get a few thousands and that is so unfair. please keep me updated on whatever you can do. thanks!!

Integrity. Honesty. Credibility. (Nah, we don’t mean it. They are just cool words)

Not long ago, I got the joy and despair of viewing many documents that were initially not to be seen, by order of the Department of Justice. The documents are, or were, in fact, evidence against Eli Lilly entirely involving their decade of deception promoting and over-medicating others with their drug called Zyprexa, which is in a class of medications called atypical anti-psychotics, yet remarkably chemically similar to the first medication in this class of drugs, which is called Clozapine that was developed by Sandoz, which is now Novartis. Today, 14 of these drugs in this class are available. In addition, these two atypical anti-psychotics are believed by some to be the most toxic to the user, even though they are no more useful to the affected patient than older similar drugs such as Haldol, which many agree are safer than drugs such as these. Launched in 1996, Eli Lilly did not appear to consider any adverse effects that may occur to those who take this drug. Yet I surmise that Eli Lilly was pleased that others were taking Zyprexa, which at the time of launch was indicated for schizophrenia, which is a mental disorder that can have the affected one experience hallucinations and abnormal thoughts. The second initial indication was for control of the manic phase of bipolar disorder.
The company, as you will likely conclude, greatly desired this medication to be a huge blockbuster at any cost. And Eli Lilly appeared to have the sales force needed to have this occur, which is the typical attractive and young individuals with charming personalities and suspected obedience. Certainly such people that will or are promoting Zyprexa will not oppose encouraging health care providers to prescribe Zyprexa for basically anything related to one’s neurological state, such as stress, anxiety, or elderly dementia. And that is what happened during this decade of reckless disregard.
Unbelievable is that soon after Eli Lilly launched Zyprexa, they appeared anxious about their disappointment regarding the speculated growth of this drug, so they had meetings throughout the nation about the importance of ‘seeding trials’, as they are a mechanism for generating needed, although fabricated data. This amazingly was done and implemented afterwards rather overtly. Even more unbelievable is that around this time, the Zyprexa sales force was instructed by Eli Lilly management to seek out clinical trial sites, along with investigators for these trials. Only stipulation is that the investigators had to either be Eli Lilly prescribing supporters or high volume prescribers. This protocol described was written internally. Anything in writing can be golden.
In fact, the promotional material Eli Lilly gave its Zyprexa reps as they mandated promotional activities to be implemented by these same reps were in fact false and misleading, while also being unbalanced and encouraged off label promotion of Zyprexa. To further saturate the corrupted minds of their zyprexa reps, they were also told to blunt widely recognized adverse effects of this medication, such as weight gain, diabetes, and lipid abnormalities.
The corrosive promotion of Zyprexa by Eli Lilly continued as they intentionally altered certain Zyprexa articles by rewriting them, followed by being reviewed internally after this art work. The purpose was for much needed commercial interest related to Zyprexa.
Then it came time to essentially buy benign groups in hopes that this would improve the growth of Zyprexa. One example is that Eli Lillly paid the American Diabetes Association for their assistance in obtaining endocrinologist consultants, which is a medical specialty that treats, among other things, diabetes. To reduce any possibility of an unexpected contingency doing this, they went ahead and hired a good sized team of diabetes educators. In 1999, Eli Lilly altered a Zyprexa glucose report with deliberate intent as well. The ADA is now quite the critic of both Lilly and Zyprexa.
Amazing alliances between Eli Lilly and the boys of Bush have existed as well. George H.W. Bush became an Eli Lilly director after leaving the CIA and lobbied to infect third world countries with Lilly medications. He also did his best to maximize tax breaks further for this industry that now employs him and his political affiliation. In fact, many members of this administration have some connection with Eli Lilly. It seems to be a revolving door issue once again.
Another tactic is that Eli Lilly, perhaps as another act of desperation hired Frontier health group for consulting needs that they perceived they needed, which is also a company that sells health insurance.
Eli Lilly created what I imagine was a very lucrative advisory board focused on Zyprexa. Amazingly, Zyprexa did have a jump in script volume because of this.
It is at this point that the medical community began to get vexed and irritated by Eli Lilly’s deceptive methods, which included the company’s own speakers that were utilized in the past. This event of Eli Lilly being ostrasized was mainly due to their overt tactics. Perhaps most disturbing was the company’s intentional holding crucial safety information related to Zyprexa. For example, Eli Lilly’s Zyprexa representatives were instructed without doubt to neutralize the legitimate concerns doctors may have about Zyprexa, if not outright fear regarding this deadly drug they now perceived. The representatives were in agreement with the promise of Eli Lilly’s management team to fill their wallets more if they maintain obedience regarding this directive. This included such physiological disorders as metabolic syndrome associated with Zyprexa, which the reps denied after this directive was given to them. Essentially, the Zyprexa representatives with Eli Lilly were trained, perhaps aggressively, to disarm negative perceptions about Zyprexa, even though these perceptions continuously proved to be valid.
Off label promotion with Zyprexa was a norm within the organization and certainly encouraged by Eli Lilly management. Encouraging doctors to prescribe Zyprexa for depression is one example. Amazingly, reflecting back on the behavioral flaws by Eli Lilly for quite some time, they did not alter their method of business even though there was a strong perception regarding this company being both aggressive and greedy. While not crimes, their actions are likely criminal. Yet according to Eli Lilly, they needed to redefine the market.
In the year 2000, Eli Lilly greatly expanded what was called their long term care sales force to expand Zyprexa in the elderly. This, as a reminder, is dangerous, as Zyprexa is harmful to older citizens- specifically pneumonia and eventual premature death. At the same time, Eli Lilly developed a strategy to neutralize the obvious weight gain associated with Zyprexa. Does the whole corporation believe U.S. citizens are without thought or intelligence?
Yet in 2002, Eli Lilly was having financial disappointments. So to stay in form, they went on a mission to develop speakers to align with them and to not educate others, but to pacify other doctors in hopes that their problems would disappear. I think trauma and all else still is there and exists regardless if you ignore the presence of such things. Anyway, after the speaker episode, Eli Lilly had the audacity to claim that Zyprexa was indeed the best in the class of atypical antipsychotics. Such a statement appears psychotic. And now the market for atypicals is about 5 billion a year. Also in this year our FDA called Eli Lilly ‘a sponsor’. I find that a bit disturbing. As disturbing as the covert meetings Eli Lilly had with the FDA as well. Well, if you are going to have a friend….. Oh, around this time, Eli Lilly also bribed select reporters to speak favorably about Zyprexa, and they did.
As the new millennium progressed over a few years, lawsuits became a concern for Eli Lilly regarding Zyprexa. Doing what any responsible corporate entity would most certainly do, the upper management of Eli Lilly had the audacity to blame the media for the way they handled their patients. Around this time, Eli Lilly needed and did hire a public relations firm because of their image crisis. About the same , time, Eli Lilly implemented a nationwide program entitled, “operation restore confidence”. I’m not sure how a fully rational and conscious group of Eli Lilly people could create something so ridiculous and unrealistic. Equally deviating from reality of Eli Lilly’s behavior is that they actually thought they could increase Zyprexa growth by hammering home astronomical efficacy with the drug which, of course, outweighs damage to the consumer.

Another failure with Eli Lilly’s last stunt as you read above. So they hired a group called Lifeplan Marketing, who convinced the organization to create a brand new market establishing Zyprexa as the standard of care. Another psychotic act by this Midwest corporation. Humans do not forget. Especially pain. At least one human wanted to let everyone know he did not, nor will he ever forget his experience as a Zyprexa representative with Eli Lilly. His name is Shahram Ahari and he aligned with a group called Pharmedout, which was created due to a state settlement from another pharmaceutical company. He spends his days now making others aware of things such as what you have read. I’ve spoken with Shahram, and I admire his assistance with others trying to correct this medical mess.
Back to the ol’ standbys. National implementation began to train the zyprexa sales force to use what was called a J.C.P. study to emphasize the numerous off label benefits of Zyprexa. At the same time, Eli Lilly determined that primary care doctors should be their number one zyprexa target. With this new focus, the sales force for zyprexa were somehow convinced to tell doctors that fatigue is really the only side effect that presents itself with zyprexa use. Again, citizens are overall not catatonic.
While on this off label role with Zyprexa, they resurrected their long term care efforts by taking on Aricept, and alzheimers drug, to encourage replacement with zyprexa. The reaction for this misbehavior was Zyprexa being removed from Medicaid in 2004. Of course, Eli Lilly rebelled, although Allan Reier was the Zyprexa product team leader at the time. He may have developed the obsurd strategy of visiting psychiatrists to assure them they will not be sued if they prescribe zyprexa for their patients.
So, now we are at a point where Eli Lilly had a flash of reality and preferred no media contact. Really?
The other tactical plan from Eli Lilly was to implement blunting techniques regarding Zyprexa. My guess is that they dragged this into a week long meeting. This of course included dodging concerns by doctors that they are normally encouraged to partner with, historically.
Another tactic authorized by Eli Lilly was to use those bonafide contract research organizations to - manufacture safety, health, and outcomes database studies. A deceptive publication plan followed. This was done as they still encouraged children to consume zyprexa- near a million of them due to an arrangement that Zyprexa will be promoted by the ADD drug Strattera.
Previously sealed and damaging documents got exposed at the end of 2006, and are accessible on the internet and some websites, such as www.furiousseasons.com. Many stories in the above documents are rather accurate and many are finally informed instead of deceived.
Dan Abshear

Dan Abshear,

After I did a google search on your name, I have a question: are you a former drug rep? or inside the system now?

Why Are Documents Presented As Evidence Are Placed Under Seal?

Not long ago, I got the joy and despair of viewing many documents that were initially not to be seen, by order of the Department of Justice, yet found their way on various locations on the internet. The documents are, or were, in fact, evidence against Eli Lilly entirely involving their decade of deception promoting and over-medicating others with their drug called Zyprexa, which is in a class of medications called atypical anti-psychotics that, while a new molecular entity by definition, is in fact chemically similar to the older and typical anti-psychotiics, such as Haldol, which have proven to be safer than the new class that appears to be quite damaging to those who ingest these atypical antipsychotics. Of the several available atypical anti-psychotics now available, Zyprexa and Clozaril, which was the first atypical anti-psychotic, are believed to be the most adverse to the consumer of these medications compared with other medications in this class of drugs.
Launched in 1996, Eli Lilly did not appear to consider any adverse effects that may occur to those who take this drug, yet it is believed that there was reason to believe that there should be caution regarding its use. With the belief that the maker of Zyprexa is and will be exonerated from any responsibility related to Zyprexa, many surmise that Eli Lilly was pleased that others were taking Zyprexa .
At the time Zyprexa was granted approval for marketing, the medication was indicated only for schizophrenia and mania that exists in those with bipolar disorder. Schizophrenia has been defined as a disease that causes the sufferer to deviate from true reality, along with visual and auditory hallucinations. Bipolar disorder is another mental disorder where the victim alternates from states of heightened neurokinetics to periods of what could be brutal depression.
Eli Lilly, known for their focus on marketing over science or research, greatly desired and hoped that Zyprexa would be a welcome blockbuster, which is a medication that exceeds a billion dollars a year in sales as a minimum. Likely because of this state of greed of Eli Lilly, they did not consider or evaluate any possible damage this flagship drug may cause others. And Eli Lilly appeared to have the obedient and manipulated sales force presumed to be a necessity for this monetary goal to occur without interference.
Pharmaceutical representatives overall are attractive and young individuals with little if any medical knowledge or training, but are determined to have charming personalities along with a perception of obedience, and this is all Eli Lilly in particular wanted from the members of their sales force. The sales vocation is normally associated to contain members with a high affinity for money, so corruptive acts such as off label promotion or overt kickbacks is not a consideration of such people, overall, as history has shown. Therefore, if Eli Lilly’s sales representatives happen to be instructed to sell Zyprexa for dementia or depression, the orders will likely be followed. Or if this sales force is instructed to pay specifically targeted doctors large amounts of money for doing little or no work for this money, it still is not a problem for the sales force to maintain their obedience to their corporate God.
A few years after Eli Lilly launched Zyprexa, they appeared anxious due to their obvious disappointment regarding the initial prediction that was speculated about the growth of this drug that was nt meeting their expectations, so they had meetings throughout the nation, known as ‘plan of action’ meetings, and concluded afterwards that there is great benefit from a monetary paradigm of implementing ‘seeding trials’, as they are a mechanism for generating needed, although fabricated data void of any scientific gain of knowledge. This amazingly was done and implemented afterwards rather overtly. Even more unbelievable is that around this time, the Zyprexa sales force was instructed by Eli Lilly management to seek out clinical trial sites, along with investigators for these trials. One voiced stipulation was that the investigators had to either be Eli Lilly prescribing supporters or high volume prescribers. This protocol described was written internally, along with the etiology for performing these sham clinical trials. Anything in writing can be golden.
In addition to the clinical trial plan of action, Eli Lilly instructed its sales force to utilize inaccurate promotional material that Eli Lilly gave its Zyprexa reps without exception, even though this material was false and misleading, which was the intent of Eli Lilly, according to others, along with this material being greatly unbalanced and suggested uses for Zyprexa that were not indicated and unproven, which can and has been harmful to patients because of this. To further saturate and corrupt the Zyprexa sales force, they were coerced to blunt assertively what are at this time widely recognized adverse effects of this medication, such as massive weight gain, along with glucose and lipid abnormalities- all of which are dangerous to the user of this medication.
The corrosive promotion of Zyprexa by Eli Lilly continued as the dangerous company intentionally altered certain Zyprexa articles by rewriting them, followed by being reviewed internally after this art work. The purpose was to stimulate what Eli Lilly believed was absent, which was much needed commercial interest related to Zyprexa.
Then it came time to essentially buy benign support groups in hopes that this would improve the growth of Zyprexa. One example is that Eli Lilly paid the American Diabetes Association for their assistance in obtaining endocrinologist consultants, which is a medical specialty that treats, among other things, diabetes. To reduce any possibility of an unexpected contingency doing this, they went ahead and hired a good sized team of diabetes educators. In 1999, Eli Lilly altered a Zyprexa report that originally illustrated the glucose problem with the medication, and did so with deliberate intent and reckless disregard for others. Eventually, the American Diabetes Association became quite the critic of Eli Lilly because of their harmful behavior..
Amazing alliances between Eli Lilly and the Bush administration have existed as well. George H.W. Bush became an Eli Lilly director after leaving the CIA and lobbied to infect third world countries with Lilly medications. He also did his best to maximize tax breaks further for this industry that now employs both himself and his political affiliation. In fact, many members of this administration have some connection with Eli Lilly. It seems to be a revolving door issue once again. One could speculate that the Zyprexa campaign continued for so long because of the relationships the maker of the drug had and has with other powerful people.
The next psychotic tactic Eli Lilly created was an advisory board paid well by this company to focus on the progressing concerns of Zyprexa. This tactic did work briefly, but did not change the view of the drug by the medical community in any way.
It is at this point that the medical community began to get vexed and irritated by Eli Lilly’s deceptive and overtly destructive tactics, which included the company’s own speakers that were utilized in the past. This event of Eli Lilly being ostracized was because of their disregard for those they are obligated to serve in the medical community. Perhaps most disturbing was the company’s intentional holding of crucial safety information related to Zyprexa even before the drug was even approvd. For example, Eli Lilly’s Zyprexa representatives were instructed without doubt to neutralize the legitimate concerns doctors may have about Zyprexa, if not outright fear regarding this deadly drug they now perceived. The representatives were in agreement of continuing to dodge or neutralize legitimate concerns about Zyprexa, with the promise of Eli Lilly’s management team to fill their wallets more if they maintain obedience regarding this directive that caused harm in the form of such physiological disorders as metabolic syndrome associated with Zyprexa, yet the sales force still denied the association due to the insistence of their employer. Essentially, the Zyprexa representatives with Eli Lilly were trained, perhaps aggressively, to disarm negative perceptions about Zyprexa, even though these perceptions continuously proved to be valid. This deeply troubled many Zyprexa representatives, as at this point they were aware of the dangers of the drug they were promoting in order to maintain employment.
Also, and of no great surprise, off label promotion with Zyprexa was a norm within the organization and certainly encouraged by Eli Lilly management. Encouraging doctors to prescribe Zyprexa for depression is one example. Amazingly, reflecting back on the behavioral flaws by Eli Lilly for quite some time, they did not alter their method of business even though there was a strong perception regarding this company being both aggressive and greedy, and likely criminal in the way they chose to conduct their business. And depression was not the only off label claim with Zyprexa. Eli Lilly considered such criminal acts as off label promotion as ‘redefining the market’. Absurd.
In the year 2000, Eli Lilly greatly expanded what was called their long term care sales force to expand Zyprexa intake in the elderly. This, as a reminder, is dangerous, as Zyprexa is harmful to older citizens- specifically pneumonia and eventual premature death result from Zyprexa intake. At the same time, Eli Lilly developed a strategy to neutralize the obvious weight gain associated with Zyprexa with other patient populations. Does the whole corporation believe U.S. citizens are without thought or intelligence?
Yet in 2002, Eli Lilly was having financial disappointments, which again did not shock many. So to stay in form, they went on a mission to develop speakers to align with them and to not educate others, but to pacify other doctors in hopes that their problems with Zyprexa would disappear. After the speaker episode, Eli Lilly had the audacity to claim that Zyprexa was indeed the best in the class of atypical antipsychotics. Such a statement appears psychotic, to say the least. And now the market for atypicals is about 5 billion a year, so there seemed to be no end as to what Eli Lilly might try next. Also in this year our FDA called Eli Lilly ‘a sponsor’. I find that a bit disturbing. As disturbing as the covert meetings Eli Lilly had with the FDA as well. Well, if you are going to have a friend….. or friends, as around this time, Eli Lilly also bribed select reporters to speak or annotate favorably about Zyprexa, and they did.
As the new millennium progressed over a few years, lawsuits became a concern for Eli Lilly regarding Zyprexa. Doing what any responsible corporate entity would most certainly do, the upper management of Eli Lilly had the audacity to blame the media for the way they handled their patients. Around this time, Eli Lilly needed and did hire a public relations firm because of their image crisis. About the same time, Eli Lilly implemented a nationwide program entitled, “Operation: restore confidence”. I’m not sure how a fully rational and conscious group of Eli Lilly people could create something so ridiculous and unrealistic. Equally deviating from reality of Eli Lilly’s behavior is that they actually thought they could increase Zyprexa growth by hammering home astronomical efficacy with the drug which, of course, does not outweigh the damage of the drug to the patient who takes it.
Another failure illustrated above caused Eli Lilly to hire a group called Lifeplan Marketing, who convinced the organization to create a brand new market establishing Zyprexa as the standard of care. Another psychotic act by this Midwest group of manipulators. Humans do not forget. Especially pain.
At least one human wanted to let everyone know he did not, nor will he ever forget his experience as a Zyprexa representative with Eli Lilly. His name is Shahram Ahari and he aligned with a group called Pharmedout, which was created due to a state settlement from another pharmaceutical company. He spends his days now making others aware of things such as what you have read. I’ve spoken with Shahram, and I admire his assistance with others trying to correct this medical mess.
Eli Lilly appears pathologically persistent in frightening ways. Next was a national implementation plan of action which focused on training the Zyprexa sales force to use what was called a J.C.P. study to emphasize the numerous off label benefits of Zyprexa. At the same time, Eli Lilly determined that primary care doctors should be their number one Zyprexa targets. With this new focus, the sales force for Zyprexa were somehow convinced to tell doctors that fatigue is really the only side effect that presents itself with Zyprexa use. Again, citizens are overall not catatonic.
While on this off label role with Zyprexa, they resurrected their long term care efforts by taking on Aricept, and alzheimers drug, and encouraged others to switch to Zyprexa. The reaction for this misbehavior was Zyprexa being removed from Medicaid in 2004.
Allan Reier was the Zyprexa product team leader at the time. He may have developed the unbelievable strategy of visiting psychiatrists to assure them they will not be sued if they prescribe zyprexa for their patients.
So, now we are at a point where Eli Lilly had a flash of reality and preferred no media contact. Really?
The other tactical plan from Eli Lilly was to re-implement blunting techniques regarding Zyprexa. My guess is that they dragged this into a week long meeting. This of course included dodging concerns by doctors that they are normally encouraged to partner with, historically. Such tactical plans of action were associated with such clever names as, ‘Viva Zyprexa’, or Zyprexa Limitless”. Maybe the next one will be ‘Zyprexa Revenue Regression’.
Another tactic authorized by Eli Lilly was to use those bonafide contract research organizations (CROs) to manufacture safety, health, and outcomes database studies. A deceptive publication plan followed. CROs are commercial research organizations that include substandard research investigators and the sponsor of these clinical trials, Eli Lilly, has the ability to alter aspects of such trials for their own benefit. This was done as they still encouraged children to consume Zyprexa- near a million of them due to an arrangement that Zyprexa will be promoted by the ADD drug Strattera.
As stated earlier, previously sealed and damaging documents got exposed at the end of 2006, and are accessible on the internet and some websites, such as www.furiousseasons.com. Perhaps the documents should have been exposed immediately instead of being held from public view. Many facts that you have read in this article are from these authentic documents that are more disturbing than fiction. The information is accurate, and many others are finally informed instead of deceived or denied their right to know.

Dan Abshear

And a special thanks for the documents regarding Zyprexa Mr. Dawdy made available to so many.